Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

09 December 2020 : Database Analysis

Identification of a 6-Gene Signature Associated with Resistance to Tyrosine Kinase Inhibitors: Prognosis for Clear Cell Renal Cell Carcinoma

Qinke Li^1ABCE, Wenbo Yang^1CD, Maoqing Lu^1DF, Ronggui Zhang^1AG*

DOI: 10.12659/MSM.927078

Med Sci Monit 2020; 26:e927078

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Table 1 Clinical characteristics of patients with clear cell renal cell carcinoma in entire cohort, training cohort, and validation cohort.

	Entire cohort	Train cohort	Validation cohort
Total risk	463	232	231
High	225	116	109
Low	238	116	122
Survival status
Living	326	162	164
Deceased	137	70	67
Age
<60	227	111	116
≥60	236	121	115
Gender
Female	163	75	88
Male	300	157	143
Grade
G1	10	6	4
G2	204	100	104
G3	180	94	86
G4	63	29	34
GX	4	2	2
Unknown	2	1	1
Stage
Stage I	232	117	115
Stage II	53	26	27
Stage III	105	51	54
Stage IV	70	37	33
Unknown	3	1	2
T stage
T1	237	120	117
T2	64	32	32
T3	153	79	74
T4	9	1	8
M stage
M0	370	186	184
M1	67	38	29
MX	24	7	17
Unknown	2	1	1
N stage
N0	208	103	105
N1	13	5	8
NX	242	124	118

Back to the Article

Medical Science Monitor eISSN: 1643-3750

Medical Science Monitor eISSN: 1643-3750